Is a creatine kinase level of 331 IU/L with acute kidney injury and elevated liver function tests indicative of rhabdomyolysis?

A CK of 331 IU/L Does NOT Meet Diagnostic Criteria for Rhabdomyolysis

A creatine kinase level of 331 IU/L is far below the diagnostic threshold for rhabdomyolysis and cannot explain the acute kidney injury and elevated liver function tests. The AKI and elevated LFTs require investigation for alternative etiologies.

Why This is Not Rhabdomyolysis

CK Threshold Requirements

The diagnostic criteria for rhabdomyolysis require CK levels significantly higher than 331 IU/L:

• Guideline-defined threshold: CK levels above five times normal (approximately 1000 IU/L) are considered a sign of rhabdomyolysis 1
• Most clinical studies use CK ≥1000 IU/L as the minimum diagnostic criterion 2, 3
• The 2009 Canadian guidelines define rhabdomyolysis as requiring CK >10,000 U/L with severe muscle pains, myoglobinuria, and potentially acute renal failure 4

Your patient's CK of 331 IU/L is approximately one-third of even the most liberal diagnostic threshold.

Clinical Context Matters

The presence of AKI with such a low CK level actually argues against rhabdomyolysis:

• In trauma-related rhabdomyolysis with crush syndrome, CK levels above 75,000 IU/L were associated with high incidence of AKI (>80%) 1
• Studies show that CK >5000 IU/L predicts likelihood of severe AKI requiring dialysis 3, 5
• Even "moderate" rhabdomyolysis requiring aggressive fluid resuscitation involves CK >15,000 IU/L 1

What You Should Investigate Instead

For the Acute Kidney Injury

Apply the KDIGO AKI criteria to stage the severity 6:

• Stage 1: Creatinine increase ≥0.3 mg/dL within 48h OR ≥1.5-fold increase from baseline
• Stage 2: Creatinine increase 2.0-2.9 times baseline
• Stage 3: Creatinine increase ≥3.0 times baseline OR ≥4.0 mg/dL

Investigate these common causes:

• Volume depletion/prerenal azotemia: Review diuretic use, assess volume status
• Nephrotoxic medications: NSAIDs, contrast agents, antibiotics (aminoglycosides, vancomycin)
• Hepatorenal syndrome (if cirrhosis present): Requires specific diagnostic criteria including lack of response to volume expansion with albumin 7, 8
• Acute tubular necrosis: From hypotension, sepsis, or other insults
• Urinary obstruction: Obtain renal ultrasound

For the Elevated LFTs

The combination of AKI and elevated LFTs suggests:

• Hepatorenal syndrome in cirrhotic patients
• Shock liver/ischemic hepatitis: Check for hypotension, cardiac issues
• Sepsis with multi-organ involvement
• Drug-induced liver injury: Review all medications
• Viral hepatitis or other primary liver disease

Important Caveats

When CK Can Be Misleading

While your patient doesn't have rhabdomyolysis, be aware that:

• Statin-related myopathy can cause myalgias with normal or minimally elevated CK 4
• Myositis is diagnosed when CK exceeds three times the upper limit of normal with muscle discomfort 4
• Some patients with severe rhabdomyolysis and extremely high CK (>150,000 IU/L) can have preserved renal function if adequately hydrated 9, 10

The Diagnostic Algorithm

For any patient with AKI and mildly elevated CK:

1. Compare CK to diagnostic thresholds: <1000 IU/L = not rhabdomyolysis
2. Assess for alternative AKI causes: Volume status, medications, obstruction
3. Evaluate the LFT pattern: Hepatocellular vs cholestatic vs mixed
4. Look for unifying diagnoses: Sepsis, shock, hepatorenal syndrome
5. Monitor trends: Serial creatinine, electrolytes, and CK if concern persists

Bottom line: A CK of 331 IU/L with AKI and elevated LFTs represents a different pathophysiologic process requiring systematic evaluation of prerenal, intrinsic renal, and hepatic causes.